本研究以北部某教學醫院參加健康檢查者為研究對象,招募134位受試者(視障者54位,一般健檢民眾80位)。採用問卷調查方式,期望了解兩組中代謝症候群之比例及生活型態情形。結果視障者與非視障者兩組之代謝症候群發生率,各為22.2%與21.3%,無統計差異,但其中檢測資料顯示,視障者之收縮壓平均值為130.6±22.7毫米汞柱,高於非視障者收縮壓121.0±15.8毫米汞柱;體脂肪率方面,視障者平均為31.3±8.6%,亦比非視障者27.9±9.4%高;視障者之空腹血糖平均為90.4±13.9 g/dL,比非視障者空腹血糖97.8±16.7 g/dL低;其餘如腰圍、舒張壓、三酸甘油酯、高密度脂蛋白膽固醇、總膽固醇、身體質量指數、白蛋白及尿酸等,兩組無統計差異。男女視障者之代謝症候群發生率,男性為25.8%,大於女性17.4%的發生率。比較其代謝症候群之相關檢測資料結果:男性腰圍平均值為88.0±11.6公分,明顯大於女性腰圍78.1±9.9公分;男性收縮壓平均值為137.6±22.6毫米汞柱,亦明顯大於女性收縮壓121.1±19.5毫米汞柱;高密度脂蛋白膽固醇方面,男性平均值為47.2±11.1 mg/dL,明顯低於女性高密度脂蛋白膽固醇54.8±12.5 mg/dL;體脂肪率、白蛋白及尿酸方面,男性平均值均明顯大於女性(p<0.05)。運動介入部份,僅8位參加為期6週之運動課程,建議每日執行運動20分鐘之結果:身體質量指數平均減少0.6 kg/m2,體脂肪平均減少1.9%,腰圍平均減少2.8公分,無統計上差異,惟運動介入後之活動型態分數自4.4±1.9分改善至2.8±1.6分(p<0.05),呈現較好的生活型態。
The purpose of this study was to identify metabolic syndrome risk factors of visually impaired people, as well as effect of exercise intervation program. Fifty-four visually impaired people (VIP) and eighty healthy people enrolled in this questionnaire survey. Visually impaired peoples’ diets were assessed using 24-hour food recall. The rate of metabolic syndrome of VIP is 22.2% (25.8% for men 17.4% for women). VIP had higher systolic blood pressure (130.6 ±22.7 vs 121.0±15.8 mmHg; respectively); body fat percentage (31.3 ±8.6 vs 27.9±9.4 %) than healthy people. VIP have lower fasting glucose level than healthy people ( 90.4 ±13.9 vs 97.9±16.7 mg/dL). Other anthropometric and biochemical variables were no significant difference between two groups. Men had a significant trend of higher waist circumference( 88 ±11.6 vs 78.11±9.9 cm) , systolic blood pressure (137.6±22.6 vs 121.1±19.5 mmHg) and uric acid than women. Women had higher HDL than men (54.8±12.5 vs 47.2±11.1 mg/dL). So Men with metabolic syndrome appear to be at higher risk for chronic disease than female in this population. The intervention exercise group (n=8) showed no significant changes in all variables, but there are trends that BMI reduced 0.6 kg/m2, body fat reduced 1.9%, and waist circumference reduced 2.8 cm. So gentle exercise might be effective in improving metabolic syndrome among a VIP, although its effect may be limited.